Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing hemodynamic monitoring techniques during liver transplantation

Official title: "Monitoraggio Emodinamico Intraoperatorio in OLT"

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06703008 · Data updated 2026-11-12

This study is testing two different ways to monitor blood flow during liver transplant surgery to see if one method can help reduce low blood pressure during the operation.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna, Emilia-Romagna)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedJanuary 1, 2026
Study endsJune 1, 2026
Registry record updatedNovember 25, 2024
Trial IDNCT06703008 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who are candidates for liver transplantation and can provide informed consent.

Probably not a fit

Patients with bleeding esophageal varices, bleeding gastro-esophageal ulcers, or gastro-esophageal anomalies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare two hemodynamic monitoring techniques during orthotopic liver transplantation (OLT) to determine if one method can reduce intraoperative hypotension time. Participants will be randomized to receive either conventional monitoring with a pulmonary artery catheter or monitoring with transesophageal echocardiography (TEE). The study will evaluate differences in intraoperative hypotension duration and secondary outcomes such as organ dysfunction and mortality. Given the complexities of OLT, effective hemodynamic management is crucial for improving patient outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved hemodynamic management during liver transplantation, potentially reducing complications and mortality.

How similar studies have gone: While the use of TEE in liver transplantation has increased, this study is among the first randomized controlled trials to evaluate its effectiveness compared to traditional methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Candidate for Liver Transplantation
* Acceptance of informed consent to participate in the study.

Exclusion Criteria:

* Bleeding esophageal varices
* Bleeding gastro-esophageal ulcer
* Gastro-esophageal anomalies (congenital, acquired or post-surgical)

Where it's running

  • IRCSS AOU di Bologna
    Bologna, Emilia-Romagna, Italy
    Recruiting

Study contacts

  • Principal investigator: Amedeo Bianchini, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Amedeo Bianchini, MD
  • Email: amedeo.bianchini@aosp.bo.it
  • Phone: 051 2143101

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.